Your browser doesn't support javascript.
loading
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
Riley, Jenny M; Cross, Ashley W; Paulos, Chrystal M; Rubinstein, Mark P; Wrangle, John; Camp, E Ramsay.
Affiliation
  • Riley JM; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
  • Cross AW; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
  • Paulos CM; Department of Pathology, Medical University of South Carolina, Charleston, South Carolina.
  • Rubinstein MP; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
  • Wrangle J; Department of Pathology, Medical University of South Carolina, Charleston, South Carolina.
  • Camp ER; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Cancer ; 124(8): 1650-1659, 2018 04 15.
Article in En | MEDLINE | ID: mdl-29315503
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Precision Medicine / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological Type of study: Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Cancer Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Precision Medicine / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological Type of study: Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Cancer Year: 2018 Document type: Article